[HTML][HTML] The efficacy of anakinra in an adolescent with colchicine-resistant familial Mediterranean fever
L Calligaris, F Marchetti, A Tommasini… - European journal of …, 2008 - Springer
Colchicine is the treatment of choice in familial Mediterranean fever (FMF) for the prevention
of both attacks and secondary amyloidosis. The overall nonresponder rate is about 5–10 …
of both attacks and secondary amyloidosis. The overall nonresponder rate is about 5–10 …
[PDF][PDF] The efficacy of anakinra in an adolescent with colchicine-resistant familial Mediterranean fever
L Calligaris, F Marchetti, A Tommasini, A Ventura - Eur J Pediatr, 2008 - Citeseer
Colchicine is the treatment of choice in familial Mediterranean fever (FMF) for the prevention
of both attacks and secondary amyloidosis. The overall nonresponder rate is about 5–10 …
of both attacks and secondary amyloidosis. The overall nonresponder rate is about 5–10 …
[PDF][PDF] The efficacy of anakinra in an adolescent with colchicine-resistant familial Mediterranean fever
L Calligaris, F Marchetti, A Tommasini, A Ventura - Eur J Pediatr, 2008 - academia.edu
Colchicine is the treatment of choice in familial Mediterranean fever (FMF) for the prevention
of both attacks and secondary amyloidosis. The overall nonresponder rate is about 5–10 …
of both attacks and secondary amyloidosis. The overall nonresponder rate is about 5–10 …
[引用][C] The efficacy of anakinra in an adolescent with colchicine-resistant familial Mediterranean fever
L Calligaris, F Marchetti, A Tommasini… - European Journal of …, 2007 - cir.nii.ac.jp
The efficacy of anakinra in an adolescent with colchicine-resistant familial Mediterranean
fever | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索 …
fever | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索 …
The efficacy of anakinra in an adolescent with colchicine-resistant familial Mediterranean fever.
L Calligaris, F Marchetti, A Tommasini… - European Journal of …, 2007 - europepmc.org
Colchicine is the treatment of choice in familial Mediterranean fever (FMF) for the prevention
of both attacks and secondary amyloidosis. The overall nonresponder rate is about 5–10 …
of both attacks and secondary amyloidosis. The overall nonresponder rate is about 5–10 …
The efficacy of anakinra in an adolescent with colchicine-resistant familial Mediterranean fever
L CALLIGARIS, F MARCHETTI, A TOMMASINI… - 2007 - ricerca.unityfvg.it
Colchicine is the treatment of choice in familial Mediterranean fever (FMF) for the prevention
of both attacks and secondary amyloidosis. The overall nonresponder rate is about 5-10 …
of both attacks and secondary amyloidosis. The overall nonresponder rate is about 5-10 …
[引用][C] The efficacy of anakinra in an adolescent with colchicine-resistant familial Mediterranean fever
L CALLIGARIS, F MARCHETTI… - European journal of …, 2008 - pascal-francis.inist.fr
The efficacy of anakinra in an adolescent with colchicine-resistant familial Mediterranean
fever CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic Databases Simple …
fever CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic Databases Simple …
The efficacy of anakinra in an adolescent with colchicine-resistant familial Mediterranean fever
L Calligaris, F Marchetti, A Tommasini… - European Journal of …, 2008 - infona.pl
Colchicine is the treatment of choice in familial Mediterranean fever (FMF) for the prevention
of both attacks and secondary amyloidosis. The overall nonresponder rate is about 5–10 …
of both attacks and secondary amyloidosis. The overall nonresponder rate is about 5–10 …
The efficacy of anakinra in an adolescent with colchicine-resistant familial Mediterranean fever.
L Calligaris, F Marchetti… - European Journal of …, 2008 - search.ebscohost.com
Colchicine is the treatment of choice in familial Mediterranean fever (FMF) for the prevention
of both attacks and secondary amyloidosis. The overall nonresponder rate is about 5–10 …
of both attacks and secondary amyloidosis. The overall nonresponder rate is about 5–10 …
[HTML][HTML] The efficacy of anakinra in an adolescent with colchicine-resistant familial Mediterranean fever
L Calligaris, F Marchetti, A Tommasini… - European Journal of …, 2008 - ncbi.nlm.nih.gov
Colchicine is the treatment of choice in familial Mediterranean fever (FMF) for the prevention
of both attacks and secondary amyloidosis. The overall nonresponder rate is about 5–10 …
of both attacks and secondary amyloidosis. The overall nonresponder rate is about 5–10 …